Have you all read this?
SAN DIEGO, June 07, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Jason Priar has joined the company as its Chief Commercial Officer. Jason is a seasoned sales leader with experience scaling businesses from early stage to hundreds of millions in revenue. He has a deep understanding of how to penetrate clinical and research markets including genetic diseases and cancer. For Bionano, he will lead the commercial teams across the platform and services businesses to drive sales and market access with third party payors.
Furthermore, their short interest has been increasing over the past few weeks and the shorts haven't yet covered. What do you think of this? I really feel it has a great potential for short squeeze to values above $10+ !
BNGO's Saphyr system is known to be far superior compared to its competitors and is expected to be worldwide adopted this year.
Jump To The Original Source